Etna, NH, United States of America

Patricia Pioli

This inventor holds 1 USPTO granted patent. Top assignees: Celdara Medical, LLC, Dartmouth College. Active years: 2026.


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Patricia Pioli: Innovator in Chimeric Antigen Receptors

Introduction

Patricia Pioli is a notable inventor based in Etna, NH (US). She has made significant contributions to the field of immunology through her innovative work on chimeric antigen receptors (CARs). Her research focuses on targeting disease-associated macrophages, which play a crucial role in various fibrotic, inflammatory, and autoimmune conditions.

Latest Patents

Patricia Pioli holds a patent for "Chimeric antigen receptors that target molecules on disease-associated macrophages and methods related thereto, and treatment of fibrotic, inflammatory and autoimmune conditions." This invention provides CARs, nucleic acid sequences encoding a CAR, and vectors that comprise these sequences. The CARs are designed to bind to target molecules expressed on disease-associated macrophages or those that are over- or aberrantly expressed in fibrosis. The invention also includes methods for treating subjects using CAR-expressing cells and pharmaceutical compositions, addressing diseases and conditions associated with DAMs.

Career Highlights

Throughout her career, Patricia has worked with various organizations, including Celdara Medical, LLC and Dartmouth College. Her work has significantly advanced the understanding and treatment of complex diseases through innovative therapeutic approaches.

Collaborations

Patricia has collaborated with notable individuals in her field, including Charles L. Sentman and Jake Reder. These collaborations have further enhanced her research and contributions to immunology.

Conclusion

Patricia Pioli's work in developing chimeric antigen receptors represents a significant advancement in the treatment of fibrotic, inflammatory, and autoimmune conditions. Her innovative approach continues to impact the field of immunology positively.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…